Leveraging large-scale biobank EHRs to enhance pharmacogenetics of cardiometabolic disease medications
Our protocols are continuously refined from real-world outcomes across 40,000+ users Studied by our Stanford PhD-led Research Team in the $101M XPRIZE Healthspan competition Prescription-grade ingredients compounded by LegitScript-certified pharmacies Read our Research AgelessRx researchers are one of 40 global teams competing in the $101M XPRIZE Healthspan competition, studying B12 with other therapies to measure real-world impacts on brain, muscle, and immune system aging
Individuals with a Focus On Preventive Health Even if you do not have type 2 diabetes or other specific health conditions, you may still benefit from exploring GLP-1 shots from BodyLogicMD if you are interested in preventive health
This applies to: 503A compounders: Until April 22, 2025 503B facilities: Until May 22, 2025 Important Caveat: The FDA may still take action regarding violations of any other statutory or regulatory requirements, such as to address findings that a product may be of substandard quality or otherwise unsafe
Scalise M, Pochini L, Galluccio M, Indiveri C